Relistor (Salix Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Relistor drug offered from Salix Pharmaceuticals, Inc.. This Opioid Antagonist [EPC],Opioid Antagonists [MoA],Quaternary Ammonium Compounds [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Salix Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | Methylnaltrexone bromide |
| SUBSTANCE NAME: | METHYLNALTREXONE BROMIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Opioid Antagonist [EPC],Opioid Antagonists [MoA],Quaternary Ammonium Compounds [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2008-08-01 |
| END MARKETING DATE: | 0000-00-00 |
Relistor HUMAN PRESCRIPTION DRUG Details:
| Item Description | Relistor from Salix Pharmaceuticals, Inc. |
| LABELER NAME: | Salix Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 150(mg/1) |
| START MARKETING DATE: | 2008-08-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 65649-150_4d9900e0-9c7d-4551-b7f4-d047b92435c8 |
| PRODUCT NDC: | 65649-150 |
| APPLICATION NUMBER: | NDA208271 |
Other METHYLNALTREXONE BROMIDE Pharmaceutical Manufacturers / Labelers:
